Apricus Biosciences, Abbott sales and marketing update

Apricus granted Abbott exclusive, Canadian rights to commercialize erectile dysfunction (ED) drug Vitaros alprostadil. Apricus is eligible to receive up to about $16 million in upfront payments and r...